INDIANAPOLIS (AP) — Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall Street had expected. Shares of the drugmaker soared 17% to an all-time-high Tuesday after Lilly said Mounjaro sales swelled…Read More
Stocks in play Medicenna Therapeutics Corp
